Cisplatin plus paclitaxel and bevacizumab versus carboplatin plus paclitaxel and bevacizumab for the first-line treatment of metastatic or recurrent cervical cancer
Yusuf Ilhan, Ali Murat Tatli, Fatih Teker, Arif Hakan Onder, Fatih Kose, Caglayan Geredeli, Mustafa Karaagac, Muhammet Ali Kaplan, Mevlude Inanc, Sabin Goktas Aydin, Aysegul Kargi, Hacı Arak, Banu Ozturk, Ali Ayberk Besen, Oguzhan Selvi, Mustafa Korkmaz, Zeynep Oruc, Oktay Bozkurt, Ahmet Bilici, Selami Bayram, Shute Ailia Dae, Mustafa Ozdogan, Hasan Senol Coskun, Sema Sezgin Goksu
International Journal of Gynecologic Cancer Apr 2022, 32 (4) 502-507; DOI: 10.1136/ijgc-2021-003165